active-site mutated heterodimeric human m-calpain with phospholipid bilayers was studied in vitro using proteinto-lipid fluorescence resonance energy transfer and surface plasmon resonance. Binding to liposomes was Ca 2q -dependent, but not selective for specific phospholipid head groups. wCa 2q x 0.5 for association with lipid bilayers was not lower than that required for the exposure of hydrophobic surface (detected by TNS fluorescence) or for enzyme activity in the absence of lipids. Deletion of domain V reduced the lipid affinity of the isolated small subunit (600-fold) and of the heterodimer (10-to 15-fold), thus confirming the proposed role of domain V for membrane binding. Unexpectedly, mutations in the acidic loop of the 'C2-like' domain III, a putative Ca 2q and phospholipid-binding site, did not affect lipid affinity. Taken together, these results support the hypothesis that in vitro membrane binding of m-calpain is due to the exposed hydrophobic surface of the active conformation and does not reduce the Ca 2q requirement for activation.
Introduction
Calpains (EC 3.4.22.52) activity. Members of the calpain superfamily have been found from lower organisms, plants and invertebrates through to mammals. As known so far, their functions are related to cytoskeleton remodelling, signal transduction, cell cycle regulation and cell death pathways (see Goll et al., 2003 , for a review). The best characterised mammalian calpains are the ubiquitous m-and m-isoforms, heterodimeric enzymes activated in vitro by Ca 2q concentrations of 3-50 mM and 0.4-0.8 mM, respectively.
They are inhibited by nanomolar concentrations of their endogenous inhibitor, calpastatin (see Wendt et al., 2004 , for a review).
m-Calpain (mCP) and m-calpain (mCP) comprise homologous, 80-kDa, large (L) 'catalytic' subunits and a common, 28-kDa, small (S) 'regulatory' subunit. Activation of the calpains by Ca 2q
, resulting in the formation of a functional active site from subdomains IIa and IIb of the L-subunit, has been investigated at the molecular level in recent years (Moldoveanu et al., 2002) . However, after four decades of research, the mechanisms by which calpain activity is spatially and temporally controlled at the low Ca 2q concentrations prevailing in resting or stimulated cells (50-300 nM) remain enigmatic (Goll et al., 2003) . Although unautolysed calpain is evidently active on protein substrates, autoproteolytic processing yields an enzyme with trimmed 76-kDa L-and 18-kDa S-subunits and a reduced Ca 2q requirement for enzymatic activity. However, the Ca 2q concentration required for activity by the autolysed enzyme in vitro (0.5-2 mM for mCP and 50-150 mM for mCP) is still far above the cellular concentrations (Goll et al., 2003) . The initial Ca 2q concentrations for autolysis in vitro are comparable to those needed for proteolytic activity of the unautolysed enzyme. Additional mechanisms have been proposed to account for the reduction in activation threshold by Ca 2q in vivo: association with membrane phospholipids (Pontremoli et al., 1985) , activator molecules (Melloni et al., 1998) , phosphorylation by protein kinases (Glading et al., 2004) , and calpain activation cascades (Tompa et al., 1996; Ono et al., 2004) . The existing reports on how these factors contribute to calpain activation are often controversial and their modes of action remain largely unexplored (Goll et al., 2003) . The putative role of membranes in calpain activation is based on the in vitro observation that membrane phospholipids reduce the Ca 2q requirement for autolysis (Coolican and Hathaway, 1984; Saido et al., 1992) . Therefore, the commonly accepted 'membrane activation hypothesis' Zalewska et al., 2004) emerged, postulating that calpain is activated at the cellular membranes, where the interaction with membranes somehow increases its Ca 2q sensitivity. Under resting conditions, only small amounts of erythrocyte calpain have been detected in the detergent-soluble fraction (Hatanaka et al., 1984) and at cellular membranes in situ (Samis and Elce, 1989) . Upon treatment with Ca 2q ionophores, added amounts of m-calpain have been found associated with the membrane fraction of lysed cells or located at the cell periphery in situ (Saido et al., 1993; Gil-Parrado et al., 2003) . Recent work revealed an increased association of calpains with the endoplasmic reticulum and the Golgi apparatus after stimulation of cells with laminin. In these studies m-calpain co-localised with phosphatidylinositol-4,5-bisphosphate (PIP 2 ) and with membrane lipid rafts (Hood et al., 2004) . However, Zalewska et al. (2004) reported that inside-out erythrocyte vesicles did not lower the Ca 2q requirement for autolysis of m-and m-calpain. To be activated by interaction with membranes, the calpains should be able to bind to the membranes at significantly lower Ca 2q concentrations than are required for enzymatic activity. To date, in vitro data on the Ca 2q requirement for the binding of isolated calpains to membranes and on their affinity for membranes are lacking.
Owing to their structural features, domain V of the Ssubunit and the 'C2-like' domain III of the L-subunit are favourite candidates for phospholipid binding sites in calpains. Domain V is an unusual, hydrophobic, Gly-rich sequence that did not diffract in X-ray crystallography (Strobl et al., 2000) . Studies with calpains lacking domain V, as well as with synthetic peptides mimicking parts of this domain, suggested a role of domain V in the interaction of calpain with membranes (Imajoh et al., 1986; Crawford et al., 1990; Arthur and Crawford, 1996; Brandenburg et al., 2002; Dennison et al., 2005) . Domain III weakly resembles C2 domains, which are Ca 2q -and phospholipid-binding modules found in a number of signalling and membrane trafficking proteins (Rizo and Sudhof, 1998; Cho, 2001 ). In the 'canonical' C2 domains, Ca 2q is complexed by negatively charged side chains of the b-strand interconnecting loops. Although these motifs in domain III of calpains differ from the classical C2 domains in sequence and topology, a cluster of acidic residues, the so-called 'acidic loop', may have the potential to bind up to three Ca 2q ions (Strobl et al., 2000) . Mutations within this 'acidic loop' have been shown to strongly affect Ca 2q -dependent activation of the calpains (Alexa et al., 2004; Fernandez-Montalvan et al., 2004) . Recent work has demonstrated that recombinant domain III of rat m-calpain and Drosophila calpain B can bind Ca 2q in a phospholipid-dependent manner and that this Ca 2q binding is abolished by deletion of the acidic loop of domain III (Tompa et al., 2001; Alexa et al., 2004) . In cell culture experiments with overexpressed EYFP fusion proteins, Gil-Parrado et al. (2003) provided evidence that domain III is required for translocation of the large subunit of mCP from the cytosol to the cell periphery.
Here we address some basic issues related to membrane binding of m-calpain in a simplified in vitro model. Active-site mutants of m-calpain were used that do not hydrolyse substrates or autolyse (and subsequently inactivate) on Ca 2q exposure, but undergo essentially the same conformational changes as the nonmutated enzyme (Fernandez-Montalvan et al., 2004) . The interaction of these recombinant proteins with free or immobilised phospholipid vesicles was analysed by fluorescence resonance energy transfer (FRET) and surface plasmon resonance (SPR) ). We determined the Ca 2q requirement and the affinity of binding to free and immobilised liposomes of various compositions. Moreover, mutated proteins were used to analyse the contributions of domain V and of the acidic loop of domain III to phospholipid binding, with the objective of delineating a molecular mechanism for the interaction of calpains with membrane lipids. We provide experimental evidence supporting the novel hypothesis that in vitro Ca 2q -dependent binding of m-calpain to lipid bilayers is mostly due to the increased hydrophobicity of the activated molecules and does not itself lower the Ca 2q demand for activation.
Results

Heterologous expression and purification of functional m-calpain variants
In a recent communication we described the generation and use of baculoviral vectors for the expression in Sf21 insect cells of full-length heterodimeric active and C115A
active-site mutated m-calpain and seven variants thereof containing further point mutations within the acidic loop of domain III (Fernandez-Montalvan et al., 2004) . The C115A variants are catalytically inactive and therefore not prone to autolysis, but fully functional in terms of Ca 2q -dependent conformational changes and binding of calpastatin. For the present study, C115A m-calpain and its mutants D402A, E403A, D405A, D406A, D408A, D412A, and E414A ( Figure 1A ) were expressed and purified using the same methodology. The recombinant proteins were obtained in high purity ( Figure 1B ).
In addition, we expressed a heterodimeric C115A mcalpain in which the first 85 N-terminal residues of the small subunit were deleted ( Figure 1A ). This variant, Lq(DV)S, lacks domain V almost completely and its truncated small subunit resembles the fragment resulting from autoproteolytic cleavage of the natural enzyme Li et al., 2004) . In contrast to rat m-calpain expressed in E. coli (Elce et al., 1997) , replacement of the small subunit by its truncated form did not improve the expression yields of the m-calpain heterodimer in insect cells. Ca 2q -dependent conformational changes detected by 2-p-toluidinylnaphthalene-6-sulfonate (TNS) fluorescence indicate that (C115A)Lq (DV)S is functional ( Figure 1C) .
For the first time we succeeded in expressing the single full-length small subunit (28 kDa) of m-calpain in sufficient quantities for functional characterisation. Western blot analysis of the lysates indicated the expression of a soluble protein of the expected molecular weight in the insect cells. Microgram quantities of the isolated small subunit were obtained after affinity purification on a calpastatin BC-peptide (subdomains B and C of calpastatin domain 1) column. SDS-PAGE of the purified protein ( Figure 1B ) showed only minor contaminating bands. Detection of Ca 2q -dependent binding to immobilised calpastatin domain 1 and to the calpastatin BC-peptide in SPR experiments confirmed that the isolated recombinant protein was properly folded and functional ( Figure  1D ). These features, however, deteriorated very rapidly during storage. Therefore, experiments with this protein . Immobilised chicken cystatin (CC), which does not interact with calpain, was used as a control.
were performed shortly after elution from the affinity column.
Bacterial expression of the single truncated small subunit, (DV)S, of m-calpain ( Figure 1A ) and its isolation by Ni-NTA affinity chromatography ( Figure 1B ) were performed as previously described Diaz et al., 2001) . The functional integrity of the protein isolated was confirmed by measuring Ca 2q -dependent conformational changes using TNS fluorescence spectroscopy (data not shown) and binding to immobilised calpastatin in SPR experiments as previously reported (Diaz et al., 2001) . Unlike the full-length small subunit, the 21-kDa protein conserved its functional properties during long-term storage.
Membrane binding of m-calpain is Ca
2H
-dependent, but lacks headgroup selectivity Interaction of the recombinant calpain proteins with free liposomes was studied by protein-to-lipid FRET measurements with N-(5-dimethylaminonaphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (dansyl DHPE)-labelled small unilamellar vesicles . To mimic more closely the lipid bilayer of biological membranes, the vesicles were captured on a Pioneer L1 sensor chip, where they fuse to form a lipid bilayer (Erb et al., 2000) . Binding of the proteins to the immobilised lipid bilayers was analysed by SPR. With both methods we observed Ca 2q -dependent binding of heterodimeric m-calpain to the model membranes ( Figure   2A , B). As can be observed from the SPR sensorgrams in Figure 2B , binding was quickly reversed when Ca 2q was washed out using a Ca 2q -free running buffer. In the presence of a saturating Ca 2q concentration (1 mM), concentration-dependent binding of mCP was observed ( Figure 2C ). By fitting the data to a 1:1 Langmuir binding model, association (k a ) and dissociation (k d ) rate constants were determined separately from the association and dissociation phases of the sensorgrams. The equilibrium dissociation constants (K d sk d /k a ) calculated from these rate constants were in the nanomolar range (Table  1) .
The SPR experiments were repeated with captured liposomes of various composition, representing different ratios of zwitterionic and anionic head groups, as well as mimicking typical plasma and nuclear envelope membranes (Stahelin et al., 2003) (Table 1) . Furthermore, in some liposomes, PI, PIP and PIP 2 (see materials and methods for abbreviations) were included. As shown in Table 1 , the lipid composition of the vesicles had no significant influence on the binding affinity (K d ). This lack of headgroup selectivity was unexpected on the basis of (i) previous papers reporting that PIP 2 , and to a lesser extent PI, were more effective than other phospholipids in lowering the Ca 2q concentration required for proteolytic activity of m-calpain (Saido et al., 1991 (Saido et al., , 1992 ; and
(ii) published results on Ca 2q -dependent membrane binding of C2 domains indicating a clear preference for either anionic (e.g., PS) or zwitterionic (e.g., PC) lipids (Stahelin et al., 2003) .
Membrane binding has a similar Ca 2H requirement as TNS binding and enzymatic activity in the absence of lipids
The free calcium concentration for half-maximal membrane binding, wCa 2q x 0.5 , was determined in Ca 2q titration experiments monitored by protein-to-lipid FRET meas- (Table   1 ). Hill coefficients (Weiss, 1997) in the region of 2 indicated positive cooperativity (see the discussion section).
Unexpectedly, the wCa 2q x 0.5 values for membrane binding were very similar to the corresponding values that we had previously determined for Ca 2q -induced conformational changes of C115A m-calpain, probed by TNS fluorescence, and for enzymatic activity of active m-calpain Table 2. in the absence of lipids (Fernandez-Montalvan et al., 2004) . Almost coincident Ca 2q titration curves were obtained for membrane binding and these effects ( Figure  2D) (Stahelin et al., 2003) . In previous work we performed an Ala-scan of the acidic residues in the acidic loop of C115A m-calpain (Fernandez-Montalvan et al., 2004) . Here we determined the Ca 2q requirement for membrane binding of these mutants by protein-to-lipid FRET ( Figure 3 , Table 2 ). Unexpectedly, abrogation of single potential Ca 2q coordination sites within the acidic loop did not increase the Ca 2q requirement, but even resulted in two-to three-fold lower wCa 2q x 0.5 values for membrane binding (Table 2) . Accordingly, a 2.5-fold lower wCa x 0.5 values for conformational changes probed by TNS binding and for enzymatic activity, which we observed in the absence of lipids (Table 2) . We explain the increased calcium sensitivity of these mutants by weakened electrostatic interactions of the acidic loop, facilitating the conformational changes required for activation (Fernandez-Montalvan et al., 2004) . In SPR experiments, the D405A mutant (D405A)LqS had similar phospholipid affinity as the 'wild-type' LqS and also lacked headgroup selectivity (Table 3) .
Deletion of domain V lowers the membrane affinity of the heterodimer
Deletion of domain V, leading to the Lq(DV)S heterodimer, resulted in 10-to 15-fold reduced membrane binding affinity measured in SPR experiments ( Figure 4A , Table 3 ). No significant effects on headgroup selectivity were observed. Previous reports (Imajoh et al., 1986; Crawford et al., 1990; Arthur and Crawford, 1996) suggesting a role for domain V in the interaction of the calpains with membranes were confirmed and extended by our quantitative data. Interestingly, even for the (D405A)Lq(DV)S variant, in which the contribution of domain V is eliminated, the additional acidic loop D405A mutation had no significant effect on lipid binding affinity (Table 3) .
Membrane affinity of the single small subunit strongly depends on the presence of domain V
To further investigate the role of domain V in membrane binding, we analysed the interaction with captured liposomes of the single full-length small subunit, S, and of a truncated mutant thereof lacking residues 1-85 of domain V, (DV)S. Surprisingly, the Ca 2q -dependent association of the full-length small subunit alone with immobilised phospholipid bilayers in SPR experiments ( Figure  4B ) was only four-to eight-fold lower than the membrane affinity of the LqS heterodimer (Table 3) . However, removal of domain V from the single small subunit, leading to the (DV)S variant, resulted in a 600-fold reduced Ca 2q -dependent affinity for immobilised bilayers when compared with the full-length small subunit ( Figure 4C , Table 3 ). Figure  2D ). These in vitro findings question a major premise of the popular 'membrane activation hypothesis'. According to this hypothesis, significant membrane binding should be observable at much lower Ca 2q concentrations than required for activation/autolysis in the absence of lipids (see the introduction section). However, because of methodological limitations (see the results section) we cannot directly exclude a small amount of binding at Ca 2q concentrations below 1 mM that might be relevant to the interaction of calpain with membranes in vivo.
When our in vitro results are applied to living cells, only a very small proportion of calpain molecules (less than 1%) would be active and able to bind to the lipids of cellular membranes. This scenario can principally explain the rather low quantities of calpain found to be associated with cellular membranes under 'resting conditions' and the added membrane-associated localisation of calpain after activation by moderately increased Ca 2q levels due to physiological stimuli or Ca 2q ionophores (see introduction). As active calpain is required for autolysis, selective binding of the active conformation to membranes would also explain the observed prevalence of autolysed calpains at the plasma membrane (Anagli et al., 1993) .
We noted a close correlation between the Ca 2q titration curves for membrane binding and those for TNS fluorescence (see Figure 2D and Table 2 ). The increase in TNS fluorescence is a well-established indicator for the exposure of hydrophobic regions on proteins (Brand and Gohlke, 1972) and has been observed previously with calpain (Hong et al., 1990) . Thus, we argue that the exposure of a hydrophobic surface after calpain transition to its active conformation (Pal et al., 2001; Dainese et al., 2002; Li et al., 2004) should be responsible for the Ca 2q -dependent membrane binding in our experiments. This type of membrane binding would occur simultaneously with or shortly after activation. A close connection between activation and membrane binding is corroborated by the Ca 2q requirement for vesicle binding of a set of domain III acidic-loop point mutants, which were previously shown to have up to seven-fold increased Ca 2q sensitivity for activation due to the disruption of electrostatic interactions of the acidic loop (Fernandez-Montalvan et al., 2004) . The wCa 2q x 0.5 values for phospholipid binding of the corresponding active-site mutants are similar to those measured previously for enzyme activity in the absence of lipids (see Figure 2D and Table 2 ). Notably, the Hill coefficients for the Ca 2q dependence of both processes were also not significantly different, e.g., 2.8 for lipid binding of (C115A)LqS m-CP (determined by FRET) and 2.4 for enzyme activity of LqS m-CP (Fernandez-Montalvan et al., 2004) . This is illustrated by almost identical shapes of the Ca 2q titration curves ( Figure 2D ). As expected from previous work (Dutt et al., 2000; Moldoveanu et al., 2004) , activation by Ca 2q is positively cooperative, but this cooperativity is likely not enhanced by the presence of lipids.
Our data are in line with earlier results questioning the role of membrane phospholipids in calpain activation (Cong et al., 1989) and with the recently reported inability of inside-out erythrocyte membranes to decrease the Ca 2q requirement for calpain autolysis (Zalewska et al., 2004) . In fact, we observed no consistent effects on the Ca 2q requirement for hydrolysis of the substrate Suc-LY-AMC by human erythrocyte calpain when we added the same phospholipid vesicles as used in the membrane binding studies (data not shown). We explain the effects Figure 1A for the design of the analytes. Solid lines, experimental data; dashed lines, data globally fitted to a 1:1 interaction model, as described in the materials and methods section.
of phospholipid vesicles on the Ca 2q requirement for calpain autolysis and activity that have been reported in numerous studies (see Goll et al., 2003, and Zalewska et al., 2004 , for references) by hydrocarbon chain-mediated stabilisation of the hydrophobic Ca 2q -activated calpain structure. This would increase the effective concentration of active molecules able to activate more molecules by (intermolecular) autoproteolysis and would reduce the formation of inactive large protein aggregates (Li et al., 2004) . Interestingly, we have observed a stabilising effect of non-ionic detergents such as Triton X-100 and Brij-35 on the Ca 2q -dependent peptidolytic activity of erythrocyte m-calpain (data not shown).
Interaction of calpain with membrane lipids is nonselective
For the first time we obtained quantitative data on the binding affinity of a calpain to lipid bilayers captured on a L1 sensor chip (Tables 1 and 3) . The dissociation constants (K d ) were within the nanomolar range and are therefore similar to those for other Ca 2q -dependent membrane binding proteins such as annexins (Tait et al., 1989) and typical C2 domain-containing proteins, such as PKC (Bazzi and Nelsestuen, 1987) , synaptotagmin (Niinobe et al., 1994) and phospholipase A2 (Kim et al., 1997) . This observation underlines the role of phospholipids as potential binding partners of activated calpain at the cellular membranes, a function once attributed exclusively to membrane-associated proteins (Inomata et al., 1990 ).
Interestingly, m-calpain showed no preference for negatively charged phospholipid headgroups (as described for most of the annexins and many C2 domain proteins, which preferentially bind phosphatidyl serine), nor for neutral/zwitterionic groups (as in the case of cPLA) (Cho, 2001; Gerke and Moss, 2002; Murray and Honig, 2002) . Unlike C2 domain-containing proteins, such as the tumour supressor PTEN , the binding affinities of m-calpain to nuclear envelope and plasma membrane-mimicking bilayers (Stahelin et al., 2003) were similar, and the affinity was not changed by inclusion of 2% PIP 2 in the liposomes. The lack of headgroup selectivity supports a membrane-binding mechanism involving hydrophobic interactions with the non-polar moieties of phospholipid vesicles. Indeed, recent work using velocity gradient centrifugation suggested that the large and small subunits of m-and m-calpain may be embedded within the organelle membranes, similar to integral membrane proteins (Hood et al., 2004) .
Lipid-binding sites of m-calpain: roles of domain V and the 'C2-like' domain III
We have analysed for the first time the individual contributions of the two putative lipid-binding sites, domain V and domain III, in the context of a 'stable', non-autolysing active-site mutated heterodimeric m-calpain.
A role for the hydrophobic Gly-rich domain V in membrane binding seems likely owing to the 10-to 15-fold reduction in the affinity for phospholipid vesicles we observed with heterodimeric mCP lacking domain V. This is strongly supported by our novel binding data for the single small subunit. Ca 2q -dependent binding of the fulllength small subunit to phospholipids had only a four-to eight-fold lower affinity than the Ca 2q -dependent binding of the heterodimer to phospholipids (Table 3) . These in vitro results are consistent with our previous observation of the Ca 2q -dependent translocation of an overexpressed small subunit to cellular membranes (Gil-Parrado et al., 2003) and the recently reported association of the small subunit with the endoplasmic reticulum and the Golgi apparatus (Hood et al., 2004 ). The ;600-fold reduced phospholipid affinity of the N-terminally truncated single small subunit, (DV)S, clearly underlines the essential contribution of domain V to lipid binding of the small subunit. It should be noted that our (DV)S mutant lacks the 56 GTAMRILGGVI 66 sequence that has been implicated in lipid binding of calpain (Arthur and Crawford, 1996; Brandenburg et al., 2002) .
The small calpain subunit is a member of the penta-EF-hand (PEF) protein family and, within this family, is most similar to sorcin and grancalcin (Maki et al., 2002) . Typical PEF proteins are composed of a Ca 2q -binding EF-hand domain corresponding to domains VI and IV of calpain, and a Pro/Gly-rich N-terminal domain of variable length, corresponding to domain V of calpain. Domain V of calpain is significantly different from the N-terminal extensions of all other PEF proteins because of its outstanding length and peculiar sequence. A common feature of non-calpain PEF proteins is their Ca 2q -induced translocation from the cytosol to membranes, where they interact with different target proteins. Depending on the protein targets, Ca 2q -dependent interactions can occur either through the Ca 2q -binding domains or, induced by Ca 2q binding to these domains, through the hydrophobic N-terminal extension (see Maki et al., 2002 , for a review). To date, little is known about the interaction of non-calpain PEF proteins with phospholipids, but recently a Ca 2q -dependent increase in hydrophobicity was reported for a PEF protein from maize lacking an N-terminal extension (Barry et al., 2006) . This is consistent with our results showing that the truncated small subunit still binds to liposomes in a Ca 2q -dependent manner, although with greatly reduced affinity.
In SPR experiments, wCa 2q x 0.5 for membrane binding of the Lq(DV)S heterodimer was approximately two-fold lower when compared to the LqS heterodimer containing the full-length small subunit. This correlates with the three-fold reduced wCa 2q x 0.5 for TNS fluorescence ( Figure  1C ) and eight-fold lower wCa The only 10-to 15-fold reduction in membrane affinity by truncation of domain V within the heterodimer points to an almost equally important contribution of the large subunit to lipid binding. The regions of the large subunit involved in membrane binding are not known. Surprisingly, the domain III acidic-loop D405A mutants with and without domain V bind to immobilised vesicles with similar affinity as the corresponding non-mutated enzymes (Table 3) . As expected from structural and functional data, the D405A point mutation should disrupt the most important residue in a putative Ca 2q /phospholipid nucleation site of the 'C2-like' domain III (Strobl et al., 2000; Alexa et al., 2004) . A number of site-directed mutagenesis studies with the C2 domains of PKCa (Bolsover et al., 2003) , cPLA (Bittova et al., 1999) , synaptotagmin (Fernandez-Chacon et al., 2002) and other C2 domain proteins have shown that neutralising mutations of the acidic residues in the Ca 2q -binding loops of C2 domains usually result in an important loss of affinity for membrane lipids. Our data suggest that the contribution of the single acidic-loop residue mutated here is minimal in the context of a heterodimeric calpain.
Conclusions
Ca 2q -dependent binding of recombinant m-calpain to the model membranes studied in this work seems to be due to the exposure of a hydrophobic surface upon activation, and thus exhibits a similar Ca 2q requirement as the activation process in the absence of lipids in vitro. It remains open to what extent these findings are relevant in vivo, because the Ca 2q concentrations used in our experiments were far above the physiological Ca 2q levels that have been shown to activate calpain in cells (Matsumura et al., 2001 ). However, Friedrich (2004) recently argued that 'the unphysiologically high Ca 2q demand for activation may turn out to be an evolutionary adjusted safety device', and the local activation of only a small portion of total calpain 'working at the initial, ascending limb of its Ca 2q saturation curve' would meet best its roles in signal transduction. We hypothesise that binding of calpain to membrane lipids during or after activation may be a biologically relevant mechanism that helps to 'concentrate' and stabilise the few active molecules, thus enabling them to cleave substrates associated with the plasma membrane or membranes of subcellular organelles. Hitherto not well understood mechanisms, such as phosphorylation of the calpains by membrane-associated protein kinases and/or interactions with membrane proteins, may lower the Ca 2q demand for activation and locally increase the number of active molecules binding to and acting at the cellular membranes.
Materials and methods
Materials
Expandீ High Fidelity DNA polymerase, restriction endonucleases and other DNA modifying enzymes were purchased from Roche (Mannheim, Germany). Oligonucleotides were synthesised by Roth (Freiburg, Germany). Protocols, media and reagents for heterologous protein expression in Spodoptera frugiperda (Sf) insect cells using the baculovirus system were from Pharmingen (BD Biosciences, Heidelberg, Germany) and Invitrogen (Groningen, The Netherlands). Heterodimeric full-length C115A m-calpain variants were expressed and purified as previously described (Fernandez-Montalvan et al., 2004) . 2-p-Toluidinylnaphthalene-6-sulfonate (TNS) and N-(5-dimethylaminonaphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (dansyl-DHPE) were purchased from Molecular Probes (Leiden, The Netherlands). 1-Palmitoyl-2-oleoylsn-glycero-3-phosphocholine (PC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (PE), 1-palmitoyl-2-oleoyl-snglyce-ro-3-wphospho-L-serinex (PS), 1-palmitoyl-2-oleoyl-snglycero-3-wphospho-rac-(1-glycerol)x (PG), L-a-phosphatidylinositol (PI), L-a-phosphatidylinositol-4-phosphate (PIP), L-a-phosphatidylinositol-4,5-bisphosphate (PIP 2 ) and cholesterol were obtained from Avanti Polar Lipids (Alabaster, AL, USA). CM5 and L-1 Pioneer sensor chips and other SPR-related reagents were purchased from Biacore (Uppsala, Sweden). Reagent-grade chemicals were obtained from Merck (Darmstadt, Germany) or Sigma-Aldrich (Taufkirchen, Germany) unless otherwise indicated.
Expression and purification of LHDVS m-calpain
The N-terminally truncated small subunit (D1-85)S of human calpain had been previously cloned in the pET-22b(q) vector with a C-terminal hexahistidine (His 6 ) tag for bacterial expression (Diaz et al., 2001) . For expression in insect cells, the sequence was subcloned into the baculovirus transfer plasmid pVL1392 by double digestion with XbaI/BamHI and subsequent ligation. Generation of a recombinant AcNPV-hCAPN4-(D1-85)S-His 6 baculovirus expressing the truncated small subunit was performed as described for the full-length variant (Fernandez-Montalvan et al., 2004) . Production of the heterodimeric Lq(DV)S m-calpain was achieved by co-infection of Sf21 cells with this new viral vector and the vector coding for the 80-kDa L subunit, AcNPV-hCAPN1-80K(C115A), as previously reported (Fernandez-Montalvan et al., 2004) . Heterologous expression was followed by one-step purification on a calpastatin BC-peptide (subdomains BqC of calpastatin domain 1) affinity column as previously described (Fernandez-Montalvan et al., 2004) .
Expression and purification of m-calpain smallsubunit variants
To produce the full-length small subunit (S, 28K), Sf21 insect cells were infected with the AcNPV-hCANPN4-28K viral vector described by Fernandez-Montalvan et al. (2004) at an MOI (multiplicity of infection) of 1. Protein purification was performed on the BC-calpastatin affinity column using the same protocol as for the heterodimeric molecule. Bacterial expression induced by isopropylthiogalactoside (IPTG) and affinity purification of the truncated (D1-85)S small subunit (21K) on a Ni-NTA column were performed as described by Diaz et al. (2001) . 
Preparation of liposome vesicles
Phospholipids were purchased in their powder form and resuspended in chloroform to create stock solutions of defined concentrations. After mixing different species in the desired molar ratios (as listed below under FRET and SPR measurements) to a total concentration of 10 mM, chloroform was evaporated from the samples under a stream of nitrogen. The mixtures were further desiccated for 2 h and the resulting lipid film was resuspended in the appropriate assay buffer by vigorous vortexing. The vesicles were downsized to small unilamellar vesicles of uniform size using a LiposoFastீ mini-extruder (Avestin Inc., Ottawa, Canada) equipped with 50-nM polycarbonate membranes following the manufacturer's guidelines.
Ca
2H -induced protein-to-lipid FRET
Binding of (C115A) m-calpain variants to dansyl-labelled liposomes was studied using the method described by Nalefski and Falke (2002) . Different dansyl-labelled small unilamellar vesicles containing PC/PE, PC/PS, PC/PG or PC/PI in a molar ratio of 70:30 supplemented with 5% dansyl-DHPE were prepared in a buffer containing 50 mM Tris/HCl, pH 7.5, 0.1 mM EGTA and 5 mM 2-mercaptoethanol. FRET measurements (excitation at 280 nm) were performed in this buffer with and without CaCl 2 at 228C in a Spex FluoroMax fluorescence spectrophotometer (Jobin Yvon, Edison, NJ, USA) equipped with a stirrer-adapted, temperature-controlled cuvette holder set. Ten mM of dansyllabelled vesicles were mixed with 0.1 mM protein solution (based on absorbance at 280 nm) to a final volume of 3 ml. Small aliquots of a CaCl 2 stock solution were added to the continuously stirred reaction volume every 2 min and the fluorescence intensity was recorded after 1.5-min incubation until saturation was reached. The increment in reaction volume was kept to -1% of the total. Control measurements were performed with MgCl 2 instead of CaCl 2 . The normalised fluorescence intensity data (emission at 510 nm) were fitted to a modified Hill equation ysF 0 qF m =wx n /(x n qwCa 2q x 0.5 n )x, where y is the fraction of maximum protein-to-membrane FRET, F 0 represents the proteinto-lipid FRET in the absence of Ca 2q , F m is the maximum protein-to-lipid FRET achieved by Ca 2q saturation, x is the actual free Ca 2q concentration (mM), n is the Hill coefficient (Weiss, 1997) , and wCa 2q x 0.5 represents the calcium concentration for half-maximal protein-to-lipid FRET.
Surface plasmon resonance (SPR) measurements
SPR sensorgrams were collected using a Biacore 2000 instrument. CM5 chips were activated as described by Diaz et al. (2001) and recombinant calpastatin domain 1 (ABC), a fragment containing subdomains BqC (BC) (Fernandez-Montalvan et al., 2004) and chicken cystatin (CC) as control were immobilised via amine groups. Binding experiments with full-length S subunit, (DV)S subunit, and heterodimeric LqS m-calpain variants were performed in 50 mM Tris/HCl, pH 7.5, 100 mM NaCl, 0.015% Brij-35, with or without 1 mM free Ca 2q at a flow rate of 20 ml/min. After each experiment the surface was regenerated with 10 ml of 3 M guanidine hydrochloride, pH 6.5.
Small unilamellar vesicles for SPR measurements (10 mM) were prepared in running buffer (10 mM Tris/HCl, pH 7.5, 150 mM NaCl) as described above with the various different lipid compositions listed in Table 1 . Pioneer L1 sensor chips were coated with 30 ml of a 0.1 mM liposome suspension (2 ml/min) followed by several washing steps with 50 ml of 50 mM NaOH (100 ml/min). Interaction experiments were performed at 20 ml/min. Initially, a 4-min pulse of 0.05-1 mM of C115A m-calpain variant or small subunit (1 mM CaCl 2 ) was injected, followed by intensive washes with regeneration solutions (see below) to block residual unspecific binding.
For Ca 2q titration experiments, solutions of the calpain variants in non-saturating concentrations w20-50 nM for full-length heterodimer, 100-200 nM for Lq(DV)S heterodimer or small subunit, all based on 280-nm absorbancex were adjusted to increasing free Ca 2q concentrations between 0 and 2 mM immediately before sample injection. After injection, the association phase was monitored over 4 min, followed by a dissociation of 8 min. At the end of the interaction experiment, the immobilised vesicles were washed at 100 ml/min with two consecutive 2-min pulses of 100 mM EDTA and 50 mM NaOH. After each set of experiments, the lipids were removed from all four flowcells by injection of 10 ml of 40 mM octyl glycoside and/or 10 ml of 20 mM CHAPS (3-w(3-cholamidopropyl)dimethylammoniox-1-propanesulfonate) at 20 ml/min, and the L1-chip was coated with fresh vesicle solution. For evaluation, the increase in resonance units (RU) during the nearly linear initial phase of association (0.1-1 or 0.1-2 min) was plotted against the free Ca 2q concentration and fitted to a modified Hill equation: ysR 0 qR m =wx n /(x n qwCa 2q x 0.5 n )x, where R 0 is the response at wCa 2q xs0, R m is the maximum response achieved by Ca 2q saturation, x is the free Ca 2q concentration (mM), n is the Hill coefficient, and wCa 2q x 0.5 is the calcium concentration for half-maximal binding (mM).
To analyse the membrane binding kinetics of calpain variants, Pioneer L1 sensor chips were coated and pretreated as described above. The running buffer (20 ml/min) was the same as before but supplemented with 1 mM CaCl 2 . Solutions containing seven to ten increasing concentrations (based on 280-nm absorbance) of the calpain variants w0.001-0.1 mM of the full-length heterodimeric variants, 0.01-0.700 mM of the Lq(DV)S heterodimeric variants or of the small subunit, 1-20 mM of the truncated (DV)S subunitx were injected in running buffer containing 1 mM free Ca 2q . Association was followed over 4 min and dissociation over 12 min. The membranes were regenerated as described above after each set of variant injections. A control lane loaded with aged vesicles of PC/PG (60:40) or PC, which showed virtually no protein binding, was subtracted to correct for bulk effects of buffer and/or sample and for non-specific binding. Association and dissociation phases of all sensorgrams were globally fitted to a 1:1 Langmuir binding model (pro-teinqprotein-binding site on the vesiclelcomplex) using the Biaevaluation 3.0 software (Biacore). The dissociation phase was analysed using the equation:
RsR 0 e -k d (t-t 0 ) where k d is the dissociation rate constant (s -1 ) and R 0 is the initial response. The association phase was evaluated using the equation:
-(k Cqk )(t-t ) ), k d is the dissociation rate constant, set to the value obtained from the dissociation phase, t 0 is the start time for the data fitting, and RI is the change in refractive index of the bulk. The equilibrium dissociation constant (K d ) was then calculated as
